Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.22.0.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Condensed Consolidated Statements of Operations        
Revenues, net $ 183,262 $ 180,409 $ 1,082,450 $ 730,698
Cost of revenues 50,394 9,581 261,823 142,183
Gross Profit 132,868 170,828 820,627 588,515
Operating expenses        
Sales and marketing 567,300 326,342 1,335,730 799,207
Research and development 368,095 460,822 634,147 1,264,647
General and administrative 725,300 1,070,243 2,222,044 3,713,183
Impairment of goodwill & intangible assets 5,200,608 7,182,053 5,200,608 7,182,053
Total operating expenses 6,861,303 9,039,460 9,392,529 12,959,090
Loss from operations (6,728,435) (8,868,632) (8,571,902) (12,370,575)
Interest expense, net 249,096 79,183 576,576 265,566
Other expense (income), net 6,314 3,066 (445,732) (50,562)
Total other expense 255,410 82,249 130,844 215,004
Net loss $ (6,983,845) $ (8,950,881) $ (8,702,746) $ (12,585,579)
Loss per share - basic $ (1.18) $ (1.75) $ (1.50) $ (2.45)
Loss per share - diluted $ (0.30) $ (1.75) $ (0.60) $ (2.45)
Weighted average number of shares outstanding - basic 5,903,360 5,126,834 5,820,654 5,126,834
Weighted average number of shares outstanding - diluted 5,903,360 5,126,834 5,820,654 5,126,834